Bareham DW - Search Results

1

E-Cigarettes: Use, Effects on Smoking, Risks, and Policy Implications.

Glantz SA, Bareham DW. Glantz SA, et al. Among authors: bareham dw. Annu Rev Public Health. 2018 Apr 1;39:215-235. doi: 10.1146/annurev-publhealth-040617-013757. Epub 2018 Jan 11. Annu Rev Public Health. 2018. PMID: 29323609 Free PMC article.

2

The Gateway Effect of E-cigarettes: Reflections on Main Criticisms.

Chapman S, Bareham D, Maziak W. Chapman S, et al. Nicotine Tob Res. 2019 Apr 17;21(5):695-698. doi: 10.1093/ntr/nty067. Nicotine Tob Res. 2019. PMID: 29660054 Free PMC article. No abstract available.

3

E-cigarettes: controversies within the controversy.

Bareham D, Ahmadi K, Elie M, Jones AW. Bareham D, et al. Lancet Respir Med. 2016 Nov;4(11):868-869. doi: 10.1016/S2213-2600(16)30312-5. Epub 2016 Oct 12. Lancet Respir Med. 2016. PMID: 27743867 No abstract available.

4

E-cigarettes: further flavours of controversy within the controversy.

Bareham D, Ahmadi K, Elie M, Jones AW, McKee M. Bareham D, et al. Lancet Respir Med. 2018 Jan;6(1):16-17. doi: 10.1016/S2213-2600(17)30467-8. Epub 2017 Dec 5. Lancet Respir Med. 2018. PMID: 29217462 No abstract available.

5

Cefiderocol in the treatment of systemic carbapenemase-producing multidrug-resistant Klebsiella pneumoniae infection.

Lampejo T, Cherian BP, Tan MGM, Wareham DW. Lampejo T, et al. Among authors: wareham dw. J Glob Antimicrob Resist. 2020 Dec;23:338-339. doi: 10.1016/j.jgar.2020.10.008. Epub 2020 Oct 30. J Glob Antimicrob Resist. 2020. PMID: 33137532 Free article. No abstract available.

6

Cefepime/sulbactam as an enhanced antimicrobial combination therapy for the treatment of MDR Gram-negative infections-authors' response.

Wareham DW, Abdul Momin MHF, Phee LM, Hornsey M, Standing JF. Wareham DW, et al. J Antimicrob Chemother. 2020 Sep 1;75(9):2713. doi: 10.1093/jac/dkaa270. J Antimicrob Chemother. 2020. PMID: 32653902 No abstract available.

7

An Invertebrate Burn Wound Model That Recapitulates the Hallmarks of Burn Trauma and Infection Seen in Mammalian Models.

Maslova E, Shi Y, Sjöberg F, Azevedo HS, Wareham DW, McCarthy RR. Maslova E, et al. Among authors: wareham dw. Front Microbiol. 2020 Jun 3;11:998. doi: 10.3389/fmicb.2020.00998. eCollection 2020. Front Microbiol. 2020. PMID: 32582051 Free PMC article.

8

Extended-spectrum β-lactamase-producing Escherichia coli in human-derived and foodchain-derived samples from England, Wales, and Scotland: an epidemiological surveillance and typing study.

Day MJ, Hopkins KL, Wareham DW, Toleman MA, Elviss N, Randall L, Teale C, Cleary P, Wiuff C, Doumith M, Ellington MJ, Woodford N, Livermore DM. Day MJ, et al. Among authors: wareham dw. Lancet Infect Dis. 2019 Dec;19(12):1325-1335. doi: 10.1016/S1473-3099(19)30273-7. Epub 2019 Oct 22. Lancet Infect Dis. 2019. PMID: 31653524 Free article.

9

Cefepime/sulbactam as an enhanced antimicrobial combination therapy for the treatment of MDR Gram-negative infections.

Wareham DW, Momin MHFA, Phee LM, Hornsey M, Standing JF. Wareham DW, et al. J Antimicrob Chemother. 2020 Jan 1;75(1):135-139. doi: 10.1093/jac/dkz420. J Antimicrob Chemother. 2020. PMID: 31617905

10

A novel plasmid-mediated polymyxin resistance determinant (mcr-1.8) in Escherichia coli recovered from broiler chickens in Brunei Darussalam.

Abdul Momin MHF, Liakopoulos A, Bean DC, Phee LM, Wareham DW. Abdul Momin MHF, et al. Among authors: wareham dw. J Antimicrob Chemother. 2019 Nov 1;74(11):3392-3394. doi: 10.1093/jac/dkz352. J Antimicrob Chemother. 2019. PMID: 31504534 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results